Performance of ROS1 fusion gene test using FFPE tissue and bronchoscopic cytologic specimen

K. Tsuji (Sapporo, Japan), N. Shinagawa (Sapporo, Japan), H. Kitai (Sapporo, Japan), T. Ikari (Sapporo, Japan), M. Sato (Sapporo, Japan), H. Takahashi (Sapporo, Japan), M. Kunisaki (Sapporo, Japan), T. Shoji (Sapporo, Japan), Y. Takashima (Sapporo, Japan), M. Furuta (Sapporo, Japan), H. Mizugaki (Sapporo, Japan), H. Asahina (Sapporo, Japan), J. Kikuchi (Sapporo, Japan), E. Kikuchi (Sapporo, Japan), Y. Oi (Tokyo, Japan), S. Nakajo (Tokyo, Japan), K. Hatanaka (Sapporo, Japan), Y. Hatanaka (Sapporo, Japan), Y. Matsuno (Sapporo, Japan), J. Sakakibara (Sapporo, Japan)

Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Session: Thoracic oncology: Treatment, diagnostic options and biology
Session type: Thematic Poster
Number: 4680
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Tsuji (Sapporo, Japan), N. Shinagawa (Sapporo, Japan), H. Kitai (Sapporo, Japan), T. Ikari (Sapporo, Japan), M. Sato (Sapporo, Japan), H. Takahashi (Sapporo, Japan), M. Kunisaki (Sapporo, Japan), T. Shoji (Sapporo, Japan), Y. Takashima (Sapporo, Japan), M. Furuta (Sapporo, Japan), H. Mizugaki (Sapporo, Japan), H. Asahina (Sapporo, Japan), J. Kikuchi (Sapporo, Japan), E. Kikuchi (Sapporo, Japan), Y. Oi (Tokyo, Japan), S. Nakajo (Tokyo, Japan), K. Hatanaka (Sapporo, Japan), Y. Hatanaka (Sapporo, Japan), Y. Matsuno (Sapporo, Japan), J. Sakakibara (Sapporo, Japan). Performance of ROS1 fusion gene test using FFPE tissue and bronchoscopic cytologic specimen. 4680

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic contribution of cytological specimen smears concurrently obtained during transthoracic cutting needle biopsy
Source: Eur Respir J 2001; 18: Suppl. 33, 391s
Year: 2001

Feasibility of EGFR mutation testing on EBUS-TBNA and bronchial biopsy samples obtained during routine practice
Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease
Year: 2012

Accuracy of mutation analysis in small tissues from transbronchial lung biopsy with radial probe endobronchial ultrasound
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018

Adequacy of EBUS-TBNA specimens for molecular testing in lung adenocarcinoma
Source: International Congress 2017 – EBUS
Year: 2017


Histological subtyping of non-small cell lung cancer using transbronchial biopsy specimens obtained with a small forceps
Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks
Year: 2017

Rinse fluid cytology specimens add value to standard bronchoscopic sampling techniques in the diagnosis of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 361s
Year: 2003

How do cytology samples compare with histology specimens when used for EGFR testing in patients with NSCLC?
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012


EGFR and KRAS mutational profiling in NSCLC cells obtained through fine needle aspiration cytology (FNAC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


The diagnostic value of bronchoscopic forceps biopsy and needle aspiration in lung cancer patients according to the histological type and the location of the tumor
Source: Eur Respir J 2002; 20: Suppl. 38, 460s
Year: 2002

Correlation of programmed death-ligand 1(PD-L1) expression in lung cancer between endobronchial ultrasound-guided transbronchial needle aspiration(EBUS-TBNA) samples and histological specimens.
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


Bronchoscopic findings in lung cancer: diagnostic yield of specimen collection method compared to histological type
Source: Eur Respir J 2005; 26: Suppl. 49, 534s
Year: 2005

Routine analysis of diagnostic, prognostic and predictive cancer markers from transbronchial (TBna) cytology needle aspiration samples
Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer
Year: 2009



EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients
Source: Eur Respir J 2012; 40: 267-269
Year: 2012


Assessment of histological samples obtained from peripheral lung lesions by using transbronchial forceps and cryobiopsies guided with radial EBUS
Source: International Congress 2018 – Linear and radial EBUS and peripheral nodules
Year: 2018


Additional value of histological specimens obtained by 19G TBNA needle in diagnosing malignant mediastinal lesions
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007



Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




Comparison of cell block (CB) preparation and direct conventional smear in cytological samples obtained by endobronchial ultrasound guide real-time needle aspiration (EBUS-rTNA)
Source: Annual Congress 2009 - The ultrasound view
Year: 2009


Cell type accuracy of bronchoscopic biopsy and transthoracic fine needle aspiration specimens in primary lung
Source: Eur Respir J 2004; 24: Suppl. 48, 673s
Year: 2004

Clinical utility of EGFR gene mutation analysis with cytological materials from bronchoscopy not histological materials
Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Year: 2011